# XISTA Science Ventures

> XISTA Science Ventures is a VC fund backing Biotechnology and Medical. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Klosterneuburg, Austria
- Total investments: 45
- Last investment: Jul 2026
- Lead investor: 58%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/xsv/
- Website: https://xista.vc/

XISTA Science Ventures is a VC fund in Klosterneuburg focused on Biotechnology and Medical. We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

## Contacts

5 contacts available for XISTA Science Ventures. Shizune tracks 9 team members at XISTA Science Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/xista?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.8M–$6.9M |
| Pre-Seed | $511k–$2.3M |
| Series A | $5.7M–$20M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 9 | 20% |
| Medical | 4 | 9% |
| Software | 3 | 7% |
| Health Care | 3 | 7% |
| Medical Device | 3 | 7% |

39 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 16 | 36% |
| Pre-Seed | 12 | 27% |
| Series A | 6 | 13% |
| Venture - Series Unknown | 1 | 2% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Austria | 15 | 33% |
| Germany | 3 | 7% |
| France | 1 | 2% |
| Slovenia | 1 | 2% |
| Philippines | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexander Fischl | Tech Transfer Associate | 0 | https://shizune.co/investors/profile/alexander-fischl |
| Alexander Schwartz | Partner | 13 | https://shizune.co/investors/profile/alexander-schwartz-fcf4 |
| Markus Wanko | Founder and Managing Partner | 8 | https://shizune.co/investors/profile/markus-wanko |
| Stephan Huber | Venture Partner | 1 | https://shizune.co/investors/profile/stephan-huber-c481 |
| Bernhard Petermeier | Partner | 2 | https://shizune.co/investors/profile/bernhard-petermeier |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rivus Batteries | Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology. | $2.3M | Seed | Jul 10, 2026 |  |
| Epitome Therapeutics | Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity. | $2.3M | Pre-Seed | Jun 30, 2026 |  |
| Ora Computing | Ora Computing is an AI infrastructure startup focused on compressing and optimizing large AI models, especially Large Language Models (LLMs), to make them cheaper and more efficient to deploy. | $4M | Seed | Jun 24, 2026 |  |
| CollimateHealth | CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer. | $6.9M | Seed | Jun 12, 2026 |  |
| Invisible-Light Labs | Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals. | $1.7M | Pre-Seed | Jun 09, 2026 |  |
| VALANX Biotech | VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. | $3.5M | Venture - Series Unknown | Mar 12, 2026 |  |
| VALANX Biotech | VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. | $3.5M | Venture - Series Unknown | Mar 12, 2026 |  |
| Factorymaker | Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage | $1.3M | Pre-Seed | Feb 19, 2026 |  |
| AVES Reality | AVES Reality is a company that creates AI-based software that generates virtual 3D maps of any location using data such as satellite and overflight images. | $3.1M | Seed | Jan 14, 2026 |  |
| vitrealab | Inspired by quantum technology, VitreaLab provides integrated optics solutions ranging from lighting to visionary displays products. | $11M | Series A | Jan 07, 2026 |  |

10 of 45 investments shown.

## Co-investors
- [xista science ventures](https://shizune.co/investors/profile/ist-cube) — VC Fund, 25 deals together
- [tecnet equity](https://shizune.co/investors/profile/tecnet-equity) — VC Fund, 10 deals together
- [seed + speed Ventures](https://shizune.co/investors/profile/seed-speed-ventures) — VC Fund, 7 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 7 deals together
- [Ventech](https://shizune.co/investors/profile/ventech-capital) — VC Fund, 6 deals together
- [aws Gründungsfonds](https://shizune.co/investors/profile/aws-grnderfonds) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Speedinvest](https://shizune.co/investors/profile/speedinvest) — VC Fund
- [tecnet equity](https://shizune.co/investors/profile/tecnet-equity) — VC Fund
- [aws Gründungsfonds](https://shizune.co/investors/profile/aws-grnderfonds) — VC Fund

## Featured in investor lists
- [All Investors in Austria](https://shizune.co/investors/investors-austria)
- [All VC Funds in Austria](https://shizune.co/investors/vc-funds-austria)
- [Biotechnology VC Funds in Austria](https://shizune.co/investors/biotechnology-vc-funds-austria)
- [Biotech Investors in Austria](https://shizune.co/investors/biotech-investors-austria)
- [Biotech VC Funds in Austria](https://shizune.co/investors/biotech-vc-funds-austria)
- [Health Care VC Funds in Austria](https://shizune.co/investors/health-care-vc-funds-austria)

## FAQ

### What does XISTA Science Ventures invest in?

XISTA Science Ventures invests primarily in Biotechnology, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 45 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is XISTA Science Ventures's check size?

XISTA Science Ventures typically joins rounds of $1.8M–$6.9M at Seed, $511k–$2.3M at Pre-Seed and $5.7M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds XISTA Science Ventures participates in.

### How do I contact XISTA Science Ventures?

Public channels for XISTA Science Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at XISTA Science Ventures?

The team at XISTA Science Ventures includes Alexander Fischl (Tech Transfer Associate), Alexander Schwartz (Partner) and Markus Wanko (Founder and Managing Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co